Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes

Clinical trial NCT06820281 · RECRUITING

Trial details

NCT number: NCT06820281
Sponsor: Victor Chang Cardiac Research Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus

Start date: 2026-07-07
Primary completion: 2027-12-31
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.